Avalon GloboCare Corp.ALBT
| Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Cash | 194 | 3 | 3 | 2 | 764,891 | 726,577 | 807,538 | 2 |
---|
Rent receivable | - | - | - | - | - | 35,395 | 33,618 | 60,526 |
---|
Rent receivable - related party | - | - | - | - | - | - | 33,600 | 74,100 |
---|
Other current assets | - | 749,796 | 149,713 | 1 | 537,470 | - | 123,046 | 247,990 |
---|
Total Current Assets | 194 | 4 | 3 | 4 | 2 | 1 | 1 | 2 |
---|
Operating lease right-of-use assets, net | - | - | - | - | - | 137,333 | 145,303 | 10,885 |
---|
Property and equipment, net | - | 295 | 48,029 | 249,555 | 601,425 | 479,115 | 361,547 | 138,294 |
---|
Investment in real estate, net | - | - | 8 | 8 | 8 | 8 | 8 | 7 |
---|
Equity method investment | - | - | - | 385,162 | 483,101 | 521,758 | 515,632 | 485,008 |
---|
Advances for equity interest purchase | - | - | - | - | - | - | - | 9 |
---|
Other non-current assets | - | - | - | - | - | - | 74,648 | 384,383 |
---|
Total Non-current Assets | - | 295 | 9 | 10 | 9 | 9 | 9 | 17 |
---|
Total Assets | 194 | 4 | 13 | 13 | 10 | 10 | 10 | 20 |
---|
Accrued professional fees | - | - | - | - | 1 | 1 | 2 | 2 |
---|
Accrued research and development fees | - | - | - | - | - | - | 928,111 | 838,001 |
---|
Accrued payroll liability and directors’ compensation | - | - | - | - | 373,083 | 154,292 | 307,043 | 223,722 |
---|
Accrued litigation settlement | - | - | - | - | - | - | - | 450,000 |
---|
Accrued liabilities and other payables | - | - | 262,174 | 859,350 | 303,911 | 297,777 | 275,320 | 283,234 |
---|
Accrued liabilities and other payables - related parties | - | - | - | - | - | - | - | 100,000 |
---|
Operating lease obligation | - | - | - | - | - | 76,379 | 151,402 | 11,437 |
---|
Note payable - related party | - | - | - | - | - | - | 390,000 | - |
---|
Total Current Liabilities | 5,600 | 160,317 | 5 | 1 | 3 | 3 | 4 | 4 |
---|
Operating lease obligation - noncurrent portion | - | - | - | - | - | 66,954 | 5,901 | - |
---|
Accrued litigation settlement - noncurrent portion | - | - | - | - | - | - | - | 450,000 |
---|
Note payable, net | - | - | - | - | - | - | - | 5 |
---|
Loan payable - related party | - | - | - | 1,000,000 | 3 | 3 | 3 | - |
---|
Total Non-current Liabilities | - | - | - | 1,000,000 | 3 | 4 | 3 | 5 |
---|
Total Liabilities | 5,600 | - | - | 2 | 6 | 6 | 7 | 9 |
---|
Preferred stock, $0.0 001 par value; 10,000,000 shares authorized; Series A Convertible Preferred Stock, $0.0001 par value; 9,000 and 0 shares issued and outstanding at December 31, 2022 and 2021, respectively. Liquidation preference $9 million at December 31, 2022 | - | - | - | - | - | - | - | 9 |
---|
Common stock, $0.0001 par value; 490,000,000 shares authorized; 10,013,576 shares issued and 9,961,576 shares outstanding at December 31, 2022; 8,897,518 shares issued and 8,845,518 shares outstanding at December 31, 2021 | 700 | 6,163 | 7,028 | 7,383 | 7,673 | 8,279 | 8,898 | 1,005 |
---|
Additional paid-in capital | - | 4 | 11 | 24 | 35 | 47 | 55 | 66 |
---|
Less: common stock held in treasury, at cost; 52,000 shares at December 31, 2022 and 2021 | - | - | - | 522,500 | 522,500 | 522,500 | 522,500 | 522,500 |
---|
Accumulated deficit | -34,506 | -53,369 | -3,517,654 | -11,291,776 | -29,361,937 | -42,041,375 | -51,131,874 | -63,062,721 |
---|
Statutory reserve | - | - | - | - | - | - | 6,578 | 6,578 |
---|
Accumulated other comprehensive loss - foreign currency translation adjustment | - | -94,568 | -91,994 | -236,860 | -257,747 | -190,510 | -165,266 | -213,137 |
---|
Total Avalon GloboCare Corp. stockholders’ equity | -5,406 | 4 | 8 | 12 | 4 | 4 | 3 | 11 |
---|
Non-controlling interest | - | - | -585,394 | -862,200 | - | - | - | - |
---|
Total Equity | - | - | 7 | 11 | 4 | 4 | 3 | 11 |
---|
Total Liabilities and Equity | 194 | 4 | 13 | 13 | 10 | 10 | 10 | 20 |
---|